Curated from a @GlomCon Podocin VF session on lupus and pregnancy by faculty powerhouses and leading voices on this area @kidneydoc101 and @shilpa_jes. Don’t miss them during the upcoming Podocin VF sessions on lupus management and pregnancy

Mentor and friend @DrRosnaYahya presenting at today’s @GlomCon with a solid, crisp presentation on IRGN. Loved the vibrant discussion infused with practical tips and pearls of wisdom from renowned experts-Dr Edwin Fernando, Dr Elias John, Dr Priyamvada

Thanks @nephrologista for entrusting me as breakout faculty at today’s @GlomCon VF session on the emerging therapies of IgAN. Such a breath of fresh air to hear from @muhgeot on the past, present and future of IgAN with expert faculty @DrRosnaYahya and Dr Russell Villanueva

Brilliant session at today’s @GlomCon VF with @Suceena providing state-of-art insights on the pathogenesis of IgAN as well as snapshot of the GraceIgAN prospective study. 2 solid presentations by our fellows @MariaSiman2709 and Anita Miranda

Thanks @ISNkidneycare for the opportunity. Join us as we unravel the latest in nephrology education in the digital space and platforms that you can be involved with SEA and Oceania. Looking forward to the session next week @nephromythri @nephrologista

RT @ISNkidneycare: 𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the ISN Oceania and South East Asia Regional Board Webinar: "Innovations in Nephrology Education" 🗣️…

RT @nephromythri: Sneak peek into a wonderful session by Dr Russell Villanueva, Philippines on “Epidemiology of glomerular disease from Sou…

Off to a blast at our session on Introduction to Clinical GN and Epidemiology with @FaridDr Dr Anthony Villanuella, @JasmineNephro Dr Dwaraka Ranganathan at today’s @GlomCon VF. Fantastic presentations by fellows during breakout sessions

RT @Dilushiwijay: Delighted to share our chapter on IRGN in #GlomPedia a newly released continuously updated e-book on Glomerular disease b…

RT @GlomCon: Join GlomCon this Sunday: Biopsy or Not Biopsy in Patients with Diabetes and Kidney Disease by Dr. Maria Jose Soler ID: 875…

RT @ISNkidneycare: 📖 This weekend don't miss our @KIReports #ISNFridaySelection: Key points in managing PLA2R-associated membranous nephrop…

RT @edgarvlermamd: The Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) from @goKDIGO is…

RT @GlomCon: 🚨 3 DAYS left to apply! Join the @GlomCon family by applying today 👉 #nephtwitter #medtwitter

RT @Dilushiwijay: @GlomCon @SaynaNorouzi @GlomConPortugal @nephrologista @tanujlamech @NephBen Summary slide on C3GN management @GlomCon @g…

7) Monitoring therapeutic response using anti PLA2R levels. We C need to better define terminology in MN treatment response-relapse, remission, refractory. Almost 70% of pts achieved immunological remission by 8 weeks with IS